{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:07:36Z","timestamp":1767910056161,"version":"3.49.0"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4631","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T22:09:48Z","timestamp":1441058988000},"page":"2213-2217","source":"Crossref","is-referenced-by-count":7,"title":["Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis"],"prefix":"10.2169","volume":"54","author":[{"given":"Hisazumi","family":"Araki","sequence":"first","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Deji","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japan Community Health Care Organization Shiga Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikata","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nagahama City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Chin-Kanasaki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Isshiki","sequence":"additional","affiliation":[{"name":"Tomita Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Arimura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japan Community Health Care Organization Shiga Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Maegawa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uzu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35: 878-883, 2000.","DOI":"10.1016\/S0272-6386(00)70258-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Haas M, Spargo BH, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 26: 740-750, 1995.","DOI":"10.1016\/0272-6386(95)90437-9"},{"key":"3","unstructured":"3. Cameron JS. Nephrotic syndrome in the elderly. Semin Nephrol 16: 319-329, 1996."},{"key":"4","unstructured":"4. Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P. The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol 17: 232-236, 1982."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ahmad H, Tejani A. Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron 84: 342-346, 2000.","DOI":"10.1159\/000045609"},{"key":"6","unstructured":"6. Sato H, Sugiyama H, Yokoyama H. Epidemiology of nephrotic syndrome in Japan. Nihon Jinzo Gakkai Shi (Japanese Journal of Nephrology) 56: 464-470, 2014 (in Japanese, Abstract in English)."},{"key":"7","unstructured":"7. Stellato T, Cappelleri A, Farina M, et al. Severe reversible acute renal failure in idiopathic nephrotic syndrome. J Nephrol 23: 717-724, 2010."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang Q, Zeng C, Cheng Z, Xie K, Zhang J, Liu Z. Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors. J Nephrol 25: 679-688, 2012.","DOI":"10.5301\/jn.5000040"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445-453, 2007.","DOI":"10.2215\/CJN.03531006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ohse T, Inagi R, Tanaka T, et al. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int 70: 1447-1455, 2006.","DOI":"10.1038\/sj.ki.5001704"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Thomas ME, Brunskill NJ, Harris KP, et al. Proteinuria induces tubular cell turnover: a potential mechanism for tubular atrophy. Kidney Int 55: 890-898, 1999.","DOI":"10.1046\/j.1523-1755.1999.055003890.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4: 481-508, 2009.","DOI":"10.2215\/CJN.04800908"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Muso E, Mune M, Hirano T, et al. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol 19: 379-386, 2015.","DOI":"10.1007\/s10157-014-0996-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22: 72-82, 1993.","DOI":"10.1016\/S0272-6386(12)70171-3"},{"key":"15","unstructured":"15. Diamond JR, Pesek I, McCarter MD, Karnovsky MJ. Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia. Am J Pathol 135: 711-718, 1989."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Knisel W, Di Nicuolo A, Pfohl M, et al. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med 234: 479-487, 1993.","DOI":"10.1111\/j.1365-2796.1993.tb00781.x"},{"key":"17","unstructured":"17. Tasaki H, Tsuda Y, Yamashita K, Himeno E, Nakashima Y. Removal of plasma fibrinogen by LDL apheresis. Jpn J Apheresis 16: 263, 1997."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Muso E, Mune M, Fujii Y, et al. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group. Kidney Int Suppl 71: S122-S125, 1999.","DOI":"10.1046\/j.1523-1755.1999.07130.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Morawietz H, Goettsch W, Brux M, et al. Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells. Atheroscler Suppl 14: 107-113, 2013.","DOI":"10.1016\/j.atherosclerosissup.2012.10.013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanhehco YC, Rux AH, Sachais BS. Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis. Transfusion 51: 1022-1029, 2011.","DOI":"10.1111\/j.1537-2995.2010.02911.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hovland A, Lappegård KT, Mollnes TE. LDL apheresis and inflammation: implications for atherosclerosis. Scand J Immunol 76: 229-236, 2012.","DOI":"10.1111\/j.1365-3083.2012.02734.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ingulli E, Tejani A. Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol 3: 254-259, 1992.","DOI":"10.1681\/ASN.V32254"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Miyazono M, Tomiyoshi Y, Kishi T, et al. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis. Ther Apher Dial 12: 333-336, 2008.","DOI":"10.1111\/j.1744-9987.2008.00596.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/17\/54_54.4631\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T04:35:28Z","timestamp":1653107728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/17\/54_54.4631\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":23,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4631","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}